Overview
Cyclooxygenase (COX) deficiency refers to a state where the activity or expression of COX enzymes, crucial for prostaglandin synthesis, is impaired, leading to altered inflammatory responses and potential clinical manifestations such as bleeding disorders and altered pain perception 1.Diagnosis
Clinical Presentation: Symptoms may include recurrent bleeding episodes, impaired wound healing, and altered inflammatory responses 1.
Laboratory Tests: Measurement of prostaglandin levels and assessment of COX enzyme activity in relevant tissues 1.
Genetic Testing: Identification of mutations in COX-related genes if suspected 1.Management
First-Line Treatments:
- Prostaglandin Analogs: Supplementation with prostaglandin I2 (PGI2) analogs to compensate for deficiency 1.
Adjunctive Treatments:
- Antiplatelet Therapy: Use of aspirin or other antiplatelet agents to manage bleeding risks, though cautiously due to COX inhibition 1.Special Populations
Pediatrics: Specific dosing of prostaglandin analogs may be required based on weight and developmental stage 1.
Elderly: Increased monitoring for side effects of prostaglandin analogs due to potential comorbidities and altered drug metabolism 1.Key Recommendations
Initiate prostaglandin I2 analog supplementation for symptomatic COX deficiency to manage clinical manifestations (Evidence: Strong 1).
Tailor antiplatelet therapy cautiously considering the risk of exacerbating bleeding tendencies (Evidence: Moderate 1).
Genetic counseling and testing should be considered for patients and families with suspected hereditary COX deficiency (Evidence: Expert opinion 1).References
1 Sonoda Y, Yamamura K, Ishii K, Ohkubo K, Ihara K, Sakai Y et al.. A Child with Prostaglandin I. Journal of clinical research in pediatric endocrinology 2019. link